| For: | Murakami K. FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations. World J Clin Oncol 2011; 2(5): 229-236 [PMID: 21611100 DOI: 10.5306/wjco.v2.i5.229] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v2/i5/229.htm |
| Number | Citing Articles |
| 1 |
Stefanie J. Hectors, Mathilde Wagner, Cecilia Besa, Wei Huang, Bachir Taouli. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience. Contrast Media & Molecular Imaging 2018; 2018 doi: 10.1155/2018/5638283
|
| 2 |
F. Montravers, J.-N. Talbot. Tomographie par émission de positons en cancérologie digestive. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2012; 7(2) doi: 10.1016/S1879-8527(12)55045-8
|
| 3 |
Julien Dimastromatteo, Jacob L. Houghton, Jason S. Lewis, Kimberly A. Kelly. Challenges of Pancreatic Cancer. The Cancer Journal 2015; 21(3) doi: 10.1097/PPO.0000000000000109
|
| 4 |
Luca Urso, Rebecca Napolitano, Giorgia Speltri, Murat Tuncel, Ilham Badrane, Licia Uccelli, Francesca Porto, Petra Martini, Alessandro Niorettini, Corrado Cittanti, Mirco Bartolomei, Alessandra Boschi. 68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives. Cancers 2025; 17(9) doi: 10.3390/cancers17091504
|
| 5 |
Cigdem Soydal, Burak Demir, Digdem Kuru Oz, Ecenur Dursun, Mine Araz, Nuriye Ozlem Kucuk. Integrated Dedicated Liver 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlations of Positron Emission Tomography with Diffusion-Weighted Imaging and Morphological Findings. Cancer Biotherapy and Radiopharmaceuticals 2025; doi: 10.1177/10849785251377528
|
| 6 |
Xin Gao, Linger Li, Siqi Zhang, Yuan Miao, Mengjie Yang, Kuan Hu, Rui Wang. Chemically Evolved Integrin α5β1-Targeted Peptide PET Tracers for Orthotopic Pancreatic Ductal Adenocarcinoma Detection. Journal of Medicinal Chemistry 2026; 69(10) doi: 10.1021/acs.jmedchem.6c00955
|
| 7 |
Donghong Wang, Zhibin Ma. Pancreatic Cancer in High-Income Asia-Pacific: A Population-Based Study. Cancer Control 2025; 32 doi: 10.1177/10732748251330713
|
| 8 |
Ryusuke Takebayashi, Kunihiko Izuishi, Yuka Yamamoto, Reiko Kameyama, Hirohito Mori, Tsutomu Masaki, Yasuyuki Suzuki. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-34
|
| 9 |
Yasemin Sanli, Baris Bakir, Serkan Kuyumcu, Zeynep Gozde Ozkan, Mine Gulluoglu, Orhan Bilge, Cuneyt Turkmen, Ayse Mudun. Hepatic Adenomatosis May Mimic Metastatic Lesions of Liver With 18F-FDG PET/CT. Clinical Nuclear Medicine 2012; 37(7) doi: 10.1097/RLU.0b013e3182443ced
|
| 10 |
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. European Radiology 2018; 28(12) doi: 10.1007/s00330-018-5425-z
|
| 11 |
|
| 12 |
Jacob L. Houghton, Brian M. Zeglis, Dalya Abdel-Atti, Robert Aggeler, Ritsuko Sawada, Brian J. Agnew, Wolfgang W. Scholz, Jason S. Lewis. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proceedings of the National Academy of Sciences 2015; 112(52) doi: 10.1073/pnas.1506542112
|
| 13 |
Kyung Jin Cho, Nam Kyu Choi, Min Ho Shin, A Ri Chong. Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection. Annals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4) doi: 10.14701/ahbps.2017.21.4.194
|
| 14 |
Thomas Winkens, William Rudakoff, Falk Rauchfuss, Christina Malessa, Utz Settmacher, Martin Freesmeyer. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma—Additional Benefit for Patients Considered for Liver Transplantation?. Clinical Nuclear Medicine 2021; 46(7) doi: 10.1097/RLU.0000000000003576
|
| 15 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; doi: 10.1007/978-3-031-05494-5_17
|
| 16 |
Eric C. Ehman, Michael S. Torbenson, Christopher L. Hallemeier, Julie K. Heimbach, Lewis R. Roberts. Evaluation and Management of Liver Masses. 2020; doi: 10.1007/978-3-030-46699-2_1
|
| 17 |
Preethi Guniganti, Andrea S. Kierans. PET/MRI of the hepatobiliary system: Review of techniques and applications. Clinical Imaging 2021; 71 doi: 10.1016/j.clinimag.2020.10.056
|
| 18 |
Annachiara Arnone, Riccardo Laudicella, Federico Caobelli, Priscilla Guglielmo, Marianna Spallino, Elisabetta Abenavoli, Anna Martini, Rossella Filice, Alessio Comis, Marco Cuzzocrea, Flavia Linguanti, Laura Evangelista, Pierpaolo Alongi. Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review. Diagnostics 2020; 10(12) doi: 10.3390/diagnostics10121042
|
| 19 |
Kim M. Pabst, Wolfgang P. Fendler, Leonie S. Jochheim, Ken Herrmann. The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update. Seminars in Nuclear Medicine 2025; 55(5) doi: 10.1053/j.semnuclmed.2025.06.011
|
| 20 |
T. Seufferlein, J.B. Bachet, E. Van Cutsem, P. Rougier. Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012; 23 doi: 10.1093/annonc/mds224
|
| 21 |
Kathryn M. Tully, Nicholas B. Sobol, Patrícia M.R. Pereira, Jason S. Lewis. Companion and Complementary Diagnostics. 2019; doi: 10.1016/B978-0-12-813539-6.00010-9
|
| 22 |
R. Ntagirabiri, S. Niyonkuru, R. Karayuba, G. Ndayisaba, G. Marerwa. Cancer du pancréas au Burundi, expérience du CHU de Kamenge. Journal Africain d'Hépato-Gastroentérologie 2012; 6(4) doi: 10.1007/s12157-012-0422-3
|
| 23 |
Nerissa Therese Viola-Villegas, Samuel L. Rice, Sean Carlin, Xiaohong Wu, Michael J. Evans, Kuntal K. Sevak, Marija Drobjnak, Govind Ragupathi, Ritsuko Sawada, Wolfgang W. Scholz, Philip O. Livingston, Jason S. Lewis. Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology. Journal of Nuclear Medicine 2013; 54(11) doi: 10.2967/jnumed.113.119867
|
| 24 |
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal Radiology 2018; 43(2) doi: 10.1007/s00261-017-1374-2
|
| 25 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; doi: 10.1007/978-3-319-26067-9_17-4
|
| 26 |
Jang Bae Moon, Suk Hee Heo, Seung Wan Kang, Jihyun Kim, Su Woong Yoo, Ayoung Pyo, Dong-Yeon Kim, Changho Lee, Seong-Young Kwon. Gadoxetic Acid-Enhanced Liver MRI for Differentiating Metabolic Predominance in Hepatocellular Carcinoma on Dual-Tracer PET/CT. Academic Radiology 2026; 33(4) doi: 10.1016/j.acra.2025.12.044
|
| 27 |
Shigeki Nagamachi, Ryuichi Nishii, Hideyuki Wakamatsu, Youichi Mizutani, Shogo Kiyohara, Seigo Fujita, Shigemi Futami, Tatefumi Sakae, Eiji Furukoji, Shozo Tamura, Hideo Arita, Kazuo Chijiiwa, Keiichi Kawai. The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT. Annals of Nuclear Medicine 2013; 27(6) doi: 10.1007/s12149-013-0719-3
|
| 28 |
KUNIHIKO IZUISHI, YUKA YAMAMOTO, HIROHITO MORI, RIKO KAMEYAMA, SHINTARO FUJIHARA, TSUTOMU MASAKI, YASUYUKI SUZUKI. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer. Oncology Reports 2014; 31(2) doi: 10.3892/or.2013.2886
|
| 29 |
Mohamad A. Eloubeidi, G. Anton Decker, Vinay Chandrasekhara, Krishnavel V. Chathadi, Dayna S. Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Kimberly Foley, Joo Ha Hwang, Terry L. Jue, Jenifer R. Lightdale, Shabana F. Pasha, John R. Saltzman, Ravi Sharaf, Amandeep K. Shergill, Brooks D. Cash, John M. DeWitt. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointestinal Endoscopy 2016; 83(1) doi: 10.1016/j.gie.2015.09.009
|
| 30 |
He N Xu, Shoko Nioka, Lin Z Li. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomarker Research 2013; 1(1) doi: 10.1186/2050-7771-1-6
|
| 31 |
Matthew E. Wampole, John C. Kairys, Edith P. Mitchell, Martha L. Ankeny, Mathew L. Thakur, Eric Wickstrom, Chin-Tu Chen. Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass. PLoS ONE 2013; 8(9) doi: 10.1371/journal.pone.0075237
|